Status:
COMPLETED
Dark Chocolate and Glucose Levels in Diabetes
Lead Sponsor:
University of British Columbia
Conditions:
Type 2 Diabetes
Type 1 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Diabetes is a growing concern in the world with an estimated 9.3% of adults, ages 20-79, with it in 2019, type 2 diabetes accounting for 90% of this total. A common recommendation for individuals with...
Detailed Description
Individuals with type 1 or type 2 diabetes (10 participants each) will consume a Ross Chocolate or conventional sugar-sweetened dark chocolate bar on two occasions in a randomized crossover trial. Blo...
Eligibility Criteria
Inclusion
- physician-diagnosed T1D or T2D of ≥1 year;
- current HbA1c of 6.5-8.5%;
- BMI: 25-40 kg/m2;
- blood pressure of \<160/99 mm Hg assessed according to guidelines;
- non-smoking;
- not on hormone replacement therapy, corticosteroids, or anti-inflammatory medications;
- 18-75 years old.
Exclusion
- Are taking more than 2 glucose lowering medications;
- Are ongoing medical treatment for diseases such as cancer, auto-immune or inflammatory disease, liver or kidney disorders;
- Have allergy, intolerance or aversion to cocoa, stevia, erythritol, inulin, or any other dietary restrictions (e.g., vegan) that will prevent them from following the standardized study diets;
- Are unable to follow remote guidance by internet or smartphone;
- Are unable to follow the controlled diet instructions;
- Are unable to read or communicate in English.
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04847999
Start Date
November 20 2020
End Date
May 4 2021
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan
Kelowna, British Columbia, Canada, V1V 3G1